{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:49:36Z","timestamp":1776919776488,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013354","name":"University of Minnesota Center for Drug Design","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejmech.2024.116604","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:20:41Z","timestamp":1718652041000},"page":"116604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase"],"prefix":"10.1016","volume":"275","author":[{"given":"Rohit","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakashkumar","family":"Dobariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Hanak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiashu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick E.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Vince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-2029","authenticated-orcid":false,"given":"Swati S.","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116604_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116604_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3182662098","article-title":"Endogenous opioid systems","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2024.116604_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100016","article-title":"Challenges and new opportunities for detecting endogenous opioid peptides in reward","volume":"2","author":"Conway","year":"2022","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.ejmech.2024.116604_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/add.15636","article-title":"Opioid use disorder and the brain: a clinical perspective","volume":"117","author":"Herlinger","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.ejmech.2024.116604_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.13563","article-title":"Estimated rates of Incident and Persistent chronic pain Among US adults, 2019-2020","volume":"6","author":"Nahin","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejmech.2024.116604_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejmech.2024.116604_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.1014768","article-title":"Endogenous opioid systems alterations in pain and opioid use disorder","volume":"16","author":"Higginbotham","year":"2022","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-neuro-110719-095912","article-title":"Endogenous opioids at the Intersection of opioid addiction, pain, and depression: the Search for a Precision medicine approach","volume":"43","author":"Emery","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib9","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1523\/JNEUROSCI.21-07-02536.2001","article-title":"Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal \u03bc opioid receptor agonists after Inflammatory injury","volume":"21","author":"Hurley","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.932546","article-title":"The role of enkephalinergic systems in substance use disorders","volume":"16","author":"Rysztak","year":"2022","journal-title":"Front. Syst. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2024.116604_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0024-3205(83)90458-7","article-title":"Release of the heptapeptide Met-enkephalin-Arg6-Phe7 and of the octapeptide Met-enkephalin-Arg6-Gly7-Leu8 from rat striatum in vitro and their rapid inactivation","volume":"33","author":"Patey","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116604_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/383535a0","article-title":"Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin","volume":"383","author":"K\u00f6nig","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116604_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/138161212799040547","article-title":"Enkephalin degrading enzymes: metalloproteases with high potential for drug development","volume":"18","author":"Khaket","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejmech.2024.116604_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3673","article-title":"Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain","volume":"11","author":"Roques","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116604_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bcp.14931","article-title":"First-in-human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324, a dual enkephalinase inhibitor for pain management","volume":"88","author":"Moss","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib16","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s11064-007-9356-3","article-title":"Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration","volume":"32","author":"Hui","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2024.116604_bib17","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1523\/JNEUROSCI.19-14-06068.1999","article-title":"Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method","volume":"19","author":"Osada","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.peptides.2003.07.012","article-title":"Analysis of conserved residues of the human puromycin-sensitive aminopeptidase","volume":"24","author":"Thompson","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2024.116604_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2006.07.019","article-title":"A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration","volume":"51","author":"Karsten","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.116604_bib20","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/hmg\/ddr065","article-title":"Puromycin-sensitive aminopeptidase (PSA\/NPEPPS) impedes development of neuropathology in hPSA\/TAU(P301L) double-transgenic mice","volume":"20","author":"Kudo","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2024.116604_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.emboj.7601592","article-title":"Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation","volume":"26","author":"Bhutani","year":"2007","journal-title":"Embo j"},{"key":"10.1016\/j.ejmech.2024.116604_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-6-29","article-title":"Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA\/NPEPPS): PSA\/NPEPPS is a possible modifier of amyotrophic lateral sclerosis","volume":"6","author":"Ren","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2024.116604_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287086","article-title":"Structure of puromycin-sensitive aminopeptidase and polyglutamine binding","volume":"18","author":"Madabushi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116604_bib24","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1073\/pnas.70.12.3866","article-title":"Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes","volume":"70","author":"Azzam","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejmech.2024.116604_bib25","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1021\/bi00720a026","article-title":"Puromycin analogs. Ribosomal binding and peptidyl transferase substrate activity of a carbocyclic analog of 8-azapuromycin","volume":"13","author":"Duquette","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116604_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejmech.2017.07.048","article-title":"Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies","volume":"139","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116604_bib27","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1021\/acschemneuro.9b00230","article-title":"Discovery of anticancer clinical candidate, tosedostat, as an analgesic agent","volume":"10","author":"Singh","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0014-2999(83)90181-4","article-title":"Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor","volume":"86","author":"Chaillet","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(85)90608-9","article-title":"In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain","volume":"117","author":"Waksman","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ki.1988.29","article-title":"Differences in puromycin aminonucleoside nephrosis in two rat strains","volume":"33","author":"Grond","year":"1988","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2024.116604_bib31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0006-2952(70)90065-1","article-title":"Metabolism of puromycin aminonucleoside in the rat: formation of nucleotide derivatives","volume":"19","author":"Kmetec","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/jm00144a027","article-title":"5'-Chloropuromycin. Inhibition of protein synthesis and antitrypanosomal activity","volume":"24","author":"Vince","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116604_bib33","doi-asserted-by":"crossref","first-page":"26931","DOI":"10.1074\/jbc.270.45.26931","article-title":"Puromycin-sensitive aminopeptidase: sequence analysis, expression, and FUNCTIONAL characterization (*)","volume":"270","author":"Constam","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116604_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-4159.1990.tb01906.x","article-title":"Comparison of the Soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopeptidases from rat","volume":"54","author":"Dyer","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.116604_bib35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.csbj.2020.04.014","article-title":"The science of puromycin: from studies of ribosome function to applications in biotechnology","volume":"18","author":"Aviner","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2024.116604_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-291X(71)80102-X","article-title":"Stereochemistry of the puromycin reaction","volume":"43","author":"Raacke","year":"1971","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116604_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-5793(88)81320-6","article-title":"Species-specific differences in the toxicity of puromycin towards cultured human and Chinese hamster cells","volume":"234","author":"Dudani","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2024.116604_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V45.1.21.21","article-title":"Toxic effect of puromycin on erythrocyte membranes which is unrelated to inhibition of protein synthesis","volume":"45","author":"Burka","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116604_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejphar.2016.05.041","article-title":"Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain","volume":"788","author":"Bonnard","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bph.15656","article-title":"The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: a novel possible therapeutic approach for opioid use disorders","volume":"180","author":"Alvarez-Perez","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116604_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2008.06.034","article-title":"Differential responses to morphine-induced analgesia in the tail-flick test","volume":"194","author":"Cecchi","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2024.116604_bib42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in Rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116604_bib43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1126\/science.abl5130","article-title":"Angiotensin-converting enzyme gates brain circuit-specific plasticity via an endogenous opioid","volume":"375","author":"Trieu","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116604_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114331","article-title":"LC-MS\/MS determination of guanabenz E\/Z isomers and its application to in vitro and in vivo DMPK profiling studies","volume":"205","author":"Xie","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2024.116604_bib45","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/1087057108323911","article-title":"High-throughput microsomal stability assay for screening new chemical entities in drug discovery","volume":"13","author":"Fonsi","year":"2008","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2024.116604_bib46","doi-asserted-by":"crossref","unstructured":"L. Xu, B. Das, C. Prakash, CYP450 enzymes in drug discovery and development: an Overview, in: Encyclopedia of Drug Metabolism and Interactions, pp. 1-35.","DOI":"10.1002\/9780470921920.edm117"},{"key":"10.1016\/j.ejmech.2024.116604_bib47","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pK(a) and protonation state prediction through Machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2024.116604_bib48","first-page":"13339","volume":"103","author":"Addlagatta","year":"2006"},{"key":"10.1016\/j.ejmech.2024.116604_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.peptides.2003.07.012","article-title":"Analysis of conserved residues of the human puromycin-sensitive aminopeptidase","volume":"24","author":"Thompson","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2024.116604_bib50","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field Accuracy on challenging Regimes of chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T09:27:00Z","timestamp":1720430820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"alternative-id":["S0223523424004847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116604","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.02.587756","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116604"}}